Aim: To assess the intraobserver repeatability of automated versusadjusted optical coherence tomography (OCT) measurements in patients with neovascular age-related macular degeneration (NVAMD). Methods: Ten eyes with NVAMD from 10 consecutive patients underwent two OCT measurements within 5 days by a single operator. Automated and adjusted central 1-mm foveal thickness and automated and adjusted total macular volume were measured in each study eye. The term ‘adjusted’ refers to manually corrected values, in which the interface landmarks for measurements are selected by the operator using Stratus® scan profiling and custom software. Bland-Altman method and bootstrap comparison of intraclass correlations (ICCs) were used for repeatability analysis. Results: Bland-Altman comparison did not reveal any statistically significant difference in any parameter, when results at first and second examination were compared (p > 0.05), indicating that the repeated measurements are similar. Further analysis was conducted using the bootstrap comparison of ICCs. The difference between adjusted and automated foveal thickness ICCs (r = 0.945 and 0.635, respectively) was significant (p = 0.031), indicating higher repeatability for adjusted foveal thickness. The ICCs for adjusted and automated total macular volume (r = 0.873 and 0.863, respectively) showed no statistically significant difference (p = 0.881). Conclusion: The repeatability of adjusted retinal thickness measurements, in which the errors of retinal boundary detection by OCT analysis software is corrected by the operator using scan profiling, is found to be higher than that of automated ones in this small group of NVAMD patients when performed by a single experienced operator.

Keywords:
Neovascular age-related macular degeneration, Optical coherence tomography, Repeatability, automated vs. adjusted optical coherence tomography measurements
1.
Klein R, Klein BE, Linton KL: Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1992;99:933–943.
2.
Leibowitz HM, Krueger DE, Maunder LR, et al: The Framingham Eye Study Monograph. VI. Macular Degeneration. Surv Ophthalmol 1980;24(suppl):428–457.
3.
Huang D, Swanson EA, Lin CP, et al: Optical coherence tomography. Science 1991;254:1178–1181.
4.
Hee MR, Izatt JA, Swanson EA, et al: Optical coherence tomography of the human retina. Arch Ophthalmol 1995;113:325–332.
5.
Puliafito CA, Hee MR, Lin CP, et al: Imaging of macular diseases with optical coherence tomography. Ophthalmology 1995;102:217–229.
6.
Hee MR, Baumal CR, Puliafito CA, et al: Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996;103:1260–1270.
7.
Van Kerckhoven W, Lafaut B, Follens I, et al: Features of age-related macular degeneration on optical coherence tomography. Bull Soc Belge Ophtalmol 2001;(281):75–84.
8.
Giovannini A, Amato GP, Mariotti C, et al: OCT imaging of choroidal neovascularisation and its role in the determination of patients’ eligibility for surgery. Br J Ophthalmol 1999;83:438–442.
9.
Ting TD, Oh M, Cox TA, et al: Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. Arch Ophthalmol 2002;120:731–737.
10.
Massin P, Vicaut E, Haouchine B, et al: Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 2001;119:1135–1142.
11.
Gurses-Ozden R, Teng C, Vessani R, et al: Macular and retinal nerve fiber layer thickness measurement reproducibility using optical coherence tomography (OCT-3). J Glaucoma 2004;13:238–244.
12.
Campochiaro PA; C99-PKC412-003 Study Group: Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412. Invest Ophthalmol Vis Sci 2004;45:922–931.
13.
Rogers AH, Martidis A, Greenberg PB, et al: Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 2002;134:566–576.
14.
Sadda SR, Wu Z, Walsh AC, et al: Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 2006;113:285–293.
15.
Ge J, Luo R, Guo Y: Corrective change of retinal thickness measured by optical coherence tomography and histologic studies (in Chinese). Yan Ke Xue Bao 1999;15:153–155.
© 2006 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.